Previous investigations demonstrated three taxonomic groups among 22 clinical isolates of Mycobacterium smegmatis. These studies were expanded to 71 clinical isolates, of which 35 (49%) (group 1) were identical to five ATCC reference strains including the type strain ATCC 19420'. Twenty-eight isolates (39%) were group 2, and eight isolates (11 %) were group 3. Isolates of groups 2 and 3 were most often associated with post-traumatic or post-surgical wound infections including osteomyelitis, were susceptible to sulfamethoxazole, amikacin, imipenem and the tetracyclines, variably resistant to clarithromycin, and susceptible (group I ) , intermediately resistant (group 2) or resistant (group 3) to tobramycin. The three groups were similar by routine biochemical and growth characteristics, but had different mycolic acid dimethoxy-4-coumarinylmethyl ester elution patterns by HPLC and different PCR-restriction enzyme patterns of a 439 bp fragment of the hsp-65 gene. Group 3 isolates differed from group 1 by 18 bp by 165 rRNA sequencing and exhibited < 25% homology by DNA-DNA hybridization, being most closely related to Mycobacterium mageritense. 
INTRODUCTION
. Although subsequently shown to have no relationship to syphilis, the organism was Mycobacterium smegmatis was first described in 1885 by Lustgarten as a cause of syphilitic penile ulcers named for the genital secretions (smigma) from whence it was isolated (Lehmann & Neumann, 1931 The EMBL accession numbers for the 165 rRNA sequences in this paper are Y12873 (ATCC 700010T), Y12871 (ATCC 700009) and Y12872 (ATCC 700504') (M0693.
0 1999 IUMS
The first modern day summary of isolates was in 1953 (Gordon & Smith, 1953) and described 56 strains, all from culture collections and none from human sources. Several studies (Tsukamura, 1984 ; Kasatiya et al., 1974) have demonstrated the frequent presence of the organism in environmental sources.
M . smegmatis is currently recognized as an aetiologic agent of bovine mastitis (Richardson, 1970) , feline and human post-traumatic wound infections (Plaus & Hermann, 199 1 ; Richardson, 1970, 197 1 ; Wallace et al., 1988; Wilkinson et al., 1982; Wolinsky & Rynearson, 1968) and human lung infections (Vonmoos et al., 1986) , although for its first 85 years it was regarded as a saprophytic organism of no clinical significance. The first well-described human case involved the lung and pleura in a patient with underlying lipoid pneumonia, and was reported less than 15 years ago (Vonmoos et al., 1986) . Since that date there have been a number of well-documented cases of human disease (Plaus & Hermann, 199 1 ; Wallace et al., 1988) .
Although early taxonomic studies of M . smegmatis prior to the 1980s suggested the species was homogeneous, these analyses were based on limited phenotypic characteristics and/or involved only a few reference isolates (Kubica et al., 1972 ; Tsukamura, 1984) . Typical tests used to distinguish this species included; a negative 3 d arylsulfatase reaction, positive iron uptake and positive nitrate reductase reactions, growth at 45 "C and in the presence of 5 Yo NaCl, utilization of D-glucitol (D-sorbitol), i-myo-inositol and D-mannitol as sole carbon sources, and late (10-14 d incubation) yellow to orange pigmentation in 50 % of isolates (Gordon & Smith, 1953; Wayne & Kubica, 1986; Tsukamura, 1984; Wallace et al., 1988) . In subsequent studies in which more recently developed taxonomic techniques were used to evaluate clinical isolates, the heterogeneity among isolates within the species became readily apparent (Steingrube et al., 1995b; Telenti et al., 1993; Wallace et al., 1988; Zhang et al., 1992) . This was first observed in a study of 22 clinical isolates of M . smegmatis in which three groups (1, 2 and 3) were identified based on differences in antibiotic susceptibilities, especially to tobramycin (Wallace et al., 1988) . These interspecies differences were reinforced by genetic methodologies including PCR restriction analysis (PRA) of selected gene sequences. Two studies based on PRA of a 439 bp sequence of the hsp-65 gene demonstrated the existence of genetic heterogeneity among isolates of M . smegmatis. In the first study, Telenti et al. (1993) reported two isolates of M . smegmatis (phenotypic or antibiogram group unknown) that differed from each other as well as from all other mycobacterial taxa with BstEII and HaeIII. Steingrube et al. (1995b) reported a second study that included nine isolates of M . smegmatis antibiogram groups 1 and 2 (Wallace et al., 1988) among 129 clinical isolates and reference strains of rapidly growing mycobacteria in which PRA with BstEII, HaeIII, AciI and CfoI (isoschizomer of HhaI) were compared. These studies found a close relationship between all nine isolates of M . smegmatis examined, although antibiogram group 1 and group 2 isolates could be separated with A d .
Heterogeneity of the j3-lactamases extracted from M . smegmatis isolates was noted in a study by Zhang et al. (1992) . They found two IEF patterns on polyacrylamide gels that were designated type 1 and type 2. The type 1 P-lactamase pattern was identified in 100 YO of 41 isolates belonging to antibiogram group 1 (Wallace et al., 1988) , while the type 2 /3-lactamase pattern was exhibited by 100 YO of 13 isolates of groups 2 and 3 (Wallace et al., 1988) .
For the past 19 years, susceptibility testing and/or identification of isolates of rapidly growing mycobacteria has been a primary function of the Mycobacteria/Nocardia laboratory at the University of Texas Health Center at Tyler (UTHCT). Seventyone isolates of M . smegmatis were identified during this period. Susceptibility testing produced three different patterns (antibiograms) among these isolates that included varying levels of susceptibility and resistance to tobramycin compared to the findings of Wallace et al. (1988) . These groups were designated as M . smegmatis group 1, group 2 and group 3.
These observations prompted a cooperative study of these three groups as well as the newly described species Mycobacterium mageritense (Domenech et al., 1997) by the International Working Group on Mycobacterial Taxonomy ( I W G M T ) . This was a polyphasic analysis, and included standard biochemical analysis, antimicrobial susceptibility testing, GLC, HPLC, PCR restriction analysis of the 65 kDa heat-shock protein gene, 16s rRNA sequencing, 16s RFLP analysis and DNA-DNA hybridization assays following recently presented guidelines for recognition of new mycobacterial species (Levy-Frebault & Portaels, 1992 Cultural and biochemical characterization. All clinical and reference isolates received prior to 1988 were identified as M . smegnzatis using standard growth and biochemical methods (Gordon & Smith, 1953; Kubica et al., 1972; Silcox et al., 1981; Wayne & Kubica, 1986; Swenson et al., 1985; Tsukamura, 1984) . This included typical colony morphology and growth within 7 d on trypticase soy agar and Middlebrook 7H 10 agar, the absence of early pigmentation (within 7 d), positive nitrate reductase and positive ironuptake reactions, a negative 3 d arylsulfatase reaction, growth at 45 "C, utilization of i-myo-inositol and D-mannitol as sole carbon sources (Silcox et al., 1981; Wallace et al., 1988) , and drug susceptibility patterns that included susceptibility to amikacin, ciprofloxacin, doxycycline and sulfamethoxazole, and resistance to cefmetazole and cefoxitin (Wallace et al., 1988) . Isolates seen after 1988 were identified on the basis of typical growth and susceptibility patterns, the absence of early pigmentation, a negative 3 d arylsulfatase reaction, growth at 45 "C, utilization of i-myoinositol and D-mannitol as sole carbon sources, and/or by PRA (Steingrube et al., 1995b; Telenti et al., 1993; Wilson et al., 1998) . Additional biochemical features including late pigmentation on 7H10 agar at 10-14 d, growth on MacConkey agar without crystal violet, degradation of para-aminosalicylate (PAS) to catechol, and utilization of citrate, L-arabinose, D-galactose, D-glucitol (D-sorbitol), Lrhamnose, D-trehalose and D-xylose, as sole carbon sources were determined for selected isolates (Silcox et al., 1981; Tsukamura, 1984) . Because all isolates were not tested simultaneously, some biochemical tests were not performed on all isolates. Susceptibility testing. Susceptibility to nine antimicrobial agents was tested by a broth microdilution method in cationsupplemented Mueller-Hinton broth as previously described (Brown et al., 1992; Swenson et al., 1985) . The antimicrobials tested included amikacin, cefmetazole, cefoxitin, ciprofloxacin, clarithromycin, doxycycline, imipenem, sulfamethoxazole and tobramycin. Because all isolates were not tested simultaneously, some isolates were not tested against all of the antimicrobials. Breakpoints used for MICs were those suggested by the National Committee for Clinical Laboratory Standards (NCCLS) (1990) for organisms that grow aerobically, except for cefoxitin, for which an MIC > 32 pg ml-' rather than > 16 pg ml-' was used as the resistance breakpoint.
For taxonomic purposes, susceptibility to tobramycin was established as an MIC of < 1 pg ml-', intermediate susceptibility as an MIC of 2-8 pg ml-', and resistance as an MIC of 3 16 pg m1-l. Isolates in the susceptible category were designated group 1, those in the intermediate category as group 2, and those that were resistant as group 3 (Wallace et al., 1988) . Susceptibilities to ethambutol, rifampin and isoniazid were performed by the proportion method on Ogawa egg medium by Tsukamura (1984) and on Mueller-Hinton agar supplemented with OADC (oleate-albumin-dextrose-catalase). Agar disk diffusion (Wallace et al., 1980) with 30 pg chloramphenicol per disk and 10 pg tobramycin per disk was performed on Mueller-Hinton agar (Becton Dickinson Microbiology Systems) for 40 and 7 1 isolates, respectively. Thirty-five isolates of M . smegmatis group 1, including the five ATCC reference strains, and 28 isolates of M . smegmatis group 2 were tested against tobramycin, while 17 M . smegmatis group 1 and 15 M . smegmatis group 2 isolates were tested against chloramphenicol. All eight isolates of M . smegmatis group 3 were tested against both tobramycin and chloramphenicol. Zone sizes were determined after 3 d incubation at 30 "C. Isolates with zone sizes > 30 mm for tobramycin were considered to be susceptible; those with 11-30 mm zone sizes were considered to be of intermediate susceptiblity, and those with zones < 10mm were considered to be resistant.
H PLC
Sample processing for fluorescence detection HPLC (FL-HPLC). A culture for FL-HPLC was inoculated onto LowensteinJensen slants and incubated at 35 "C for 5 d. A sterile wooden applicator stick was used to transfer a small amount of cell mass to a test tube containing 2.0 ml 25 % potassium hydroxide in methanol/water (1 : 1, v/v). The tube was capped and autoclaved for 60 min at 12 1 "C. After the tube was cooled to room temperature, 1.5 ml chloroform and 1.8 ml concentrated hydrochloric acid/water (1 : 1, v/v) were added. The tube was vortexed for 60 s and the layers were allowed to separate. The chloroform layer was transferred to a 13 x 100 mm screw cap test tube and evaporated to dryness at 85 "C at 30% full vortex speed in a Rapid-Vap (Labconco). One hundred microlitres of 2 YO potassium bicarbonate in water/methanol (1 : 1, v/v) were added to the tube and evaporated to dryness at 85 "C. The tube was cooled to room temperature and 100 pl chloroform containing 125 pg 4-bromomethyl-6-7 dimethoxycoumarin and 15 pg 18-crown-6 ether (both from Sigma) were added. The tube was sealed with a Teflon-lined cap and heated at 90 "C for 20 min. After the tube was cooled to room temperature, 1.5 ml chloroform and 1 ml concentrated hydrochloric acid/water/methanol (1 : 1 : 2, by vol.) were added. The tube was vortexed briefly and the layers were allowed to separate. The chloroform layer was transferred to a tube and evaporated. The sample was dissolved in 300 pl chloroform that contained 50 ng ml-' and 200 ng ml-', respectively, of Low and High Molecular Mass Internal Standards (LMWS and HMWS) for fluorescence-HPLC (Ribi Immunochem Research); 100 pl of this solution was transferred to an autosampler vial that contained 400 p1 chloroform.
FL-HPLC. HPLC was performed with a Hewlett Packard 1050 series pump and autosampler. The pump gradient has been described previously (Butler et al., 1996a) . Sample injection volume was 5 pl. Mycolates were separated with a Beckman 4.6 x 70 mm, 3 pm C-18 particle cartridge column (Beckman) maintained at 35 "C. Mycolates were detected with a Jasco FP-920 fluorescence detector (Jasco) equipped International Journal of Systematic Bacteriology 49 B. A. Brown and others with a high-sensitivity photomultiplier (gain = 1000) and a 16 pl flowcell. Excitation and emission were set at 351 and 430 nm, respectively. Emission bandwidth was 18 nm. The digital filter was used (S = 3) and the signal was collected at 2 Hz. M . smegmatis groups 1,2 and 3 strains were processed and analysed by a standardized UV-absorbance HPLC (UV-HPLC) method (Butler et al., 1996a) .
Chromatographic data analysis. Raw FL-HPLC chromatograms were imported into Pirouette Software, version 2.03 (Infometrix). Adjusted retention times (ART) for each chromatogram were derived by alignment of the two internal standards, as has been done previously with mycolic acid pbromophenacyl esters detected by UV absorption (Butler et al., 1996a, b) . Hierarchical cluster analysis was performed on raw normalized chromatographic data from the region between the two internal standards using a mean-centred data preprocess.
GLC. Whole-cell fatty acid analyses were performed by GLC with the Microbial Identification System (MIS; MIDI). The MIS included an HP model 6890A gas chromatograph equipped with a 25 m x 0.2 mm fused silica capillary column, a flame-ionization detector, an automatic sampler, an integrator and a microcomputer (Hewlett Packard). Peaks were automatically identified and quantified by the system. Organism identification was done by comparison with the MIDI mycobacterial library database (version 3.9). The manufacturer's protocol was followed for all stages of cultivation, extraction, saponification, methylation and chromatography procedures. by HPLC were performed as previously described by Mesbah et al. (1989) PRA of a 439 bp segment of the hsp-65 gene. All isolates of M . smegmatis group 3 and M . mageritense, and selected isolates of M . smegmatis group 1 and M . smegmatis group 2 were subjected to PCR amplification of a 439 bp segment of the hsp-65 gene as described by Telenti et al. (1993) . Cells were grown on tryptic soy agar and ground cell supernatants were used as DNA templates as previously described (Steingrube et al., 1995b; Wilson et al., 1998) using the appropriate positive and negative controls (Telenti et al. , 1993) .
Screening of multiple commercial restriction endonucleases in previous studies (Steingrube et al., 1995a (Steingrube et al., , b, 1997 resulted in the selection of seven restriction endonucleases (BstEII, HaeIII, HhaI, MspI Hinfl, BsaHI and AciI) (New England Biolabs and Promega) for further characterization of isolates. Enzymes were used according to the manufacturer's recommendation, except for BsaHI. To achieve complete digestion with BsaHI, acetylated BSA was substituted for BSA and the digestions mixture was incubated at 60 "C for 1 h.
Restriction fragments were electrophoresed on 3 YO Metaphor agarose (4 bp resolution; FMC Bioproducts) containing ethidium bromide (0.625 pg ml-') in a Mini-SubCell electrophoresis system (Bio-Rad) at 95 V for 1.5-2.0 h. Fragment sizes (in bp) were estimated on a computerized Bio Image system (Millipore). Fragments of 60 bp were disregarded as PCR primer artifacts as recommended by Telenti et al. (1993) . 165 rRNA sequencing. The 16s rRNA regions chosen for analysis were based on previously published sequence data available in the EMBL/GenBank database (Domenech et al., 1997; Kazda et al., 1992; Kirschner et al., 1992a Kirschner et al., , b, 1993a Pitulle et al., 1992; Rogall et al., 1990; Stahl & Urbance, 1990) . GenBank accession numbers for selected 16s rRNA sequences used for comparison studies were as follows: M . fortuitum ATCC 6841T, X52933; M. fortuitum third biovariant complex sorbitol-positive ATCC 49403T, X65528 ; M . fortuitum third biovariant complex sorbitolnegative ATCC 49404T, X65529 ; Mycobacterium abscessus ATCC 19977T, X82235; M . chelonae ATCC 35752T, X82236 ; Mycobacteriurn mucogenicum, X8077 1 ; M . smegmatis ATCC 14468, X52922 ; Mycobacterium mageritense ATCC 700351T, X99938 ; and Mycobacterium peregrinum, X52921. The methods used for DNA extraction, gene fragment amplification of 16s rRNA, and sequence determination have been described previously (Rogall et al., 1982; Bottger, 1989 , Boddinghaus et al., 1990 Edwards et al., 1989; Kirschner et al., 1993a, b; Rogall et al., 1990) . Briefly, to extract nucleic acids, a colony from a Lowenstein-Jensen slant was suspended in 500 p1 of 10 mM Tris-1 mM EDTA (TE). The bacterial pellet was harvested by centrifugation in a microcentrifuge and then dispersed in 100 p1 of TE containing acid-washed glass beads (diameter, 100 pm; Sigma). A tissue disintegrator (H. Mickle) was used to disrupt the cells (2min at the maximum speed). After centrifugation for 5 min, 5 pl of the supernatant was used for PCR. After amplification of the 5' part of the 16 S rRNA gene using primers AGAGTTTGATCCTGGCTCAG (positions 8-28) in combination with TGCACACAGGCCACAAG-GGA (positions 1046-1026), the nucleic acid sequences of hypervariable regions A and B (Kirschner et al., 1993b) were determined. Based on the grouping determined by this comparison, representative strains were chosen for nearly complete 16s rRNA analysis. The 3' part of the 16s rRNA gene was amplified using primers GTGTGGGTTTCCT-TCCTTGG (positions 830-847) and AAGGAGGTGATC-CAGCCGCA (positions 1542-1 522). Sequence information on nearly the complete 16s rRNA gene was obtained by PCR-mediated Taq-cycle sequencing using an ABI 373 sequencer (Hultman et al., 1989) . The sequences which we obtained were aligned with selected 16s rRNA sequences as described previously (Rogall et al., 1990) . For phylogenetic analyses, only those 16s rRNA regions corresponding to Escherichia coli positions 126-554, 8941082 and 1101-1332 that were available for rapidly growing mycobacterial species were included. Pairwise (Hamming) distances were calculated by weighting nucleotide differences and insertions-deletions equally. A phylogenetic tree was constructed by using the neighbourliness method. (Rogall et al., 1990; Sourdis & Nei, 1998) . DNA-DNA hybridization experiments. DNA-DNA homology experiments were performed as described previously (Domenech et al., 1997) . Genomic DNA (0.5 pg) was labelled in vitro using a nick translation labelling kit (Boehringer Mannheim) and 30 pCi [ C X -~~P I~C T P (Amersham). Portions (1 pg) of each unlabelled DNA were bound to nylon membrane filters (Amersham) by using alkaline denaturation and UV fixation. Hybridizations were carried out under stringent conditions for 40 h. The filters were then washed and counted with a liquid scintillation counter (Beckman). The relative binding ratios for each strain were calculated from the counts of homologous DNA bound and were expressed as percentages. Control strains included M . jortuiturn ATCC 6841T and M . phlei IMRU 500. RFLP analysis of the 16s rRNA gene. RFLP analysis of the 16s rRNA gene were performed using genomic DNA digested with the restriction endonucleases BarnHI and PstI. The digests were separated by electrophoresis on horizontal gel slabs containing 0.75 % (w/v) agarose, then transferred to nylon membrane filters (Amersham). An 804 bp fragment of the 16s rRNA gene of M..fortuitum type strain ATCC 684l'was obtained by PCR and used as a probe. For DNA amplification the Rl and Rc2 oligonucleotide sequences from the Mycobacteriurn bovis BCG 16s rRNA sequence were used in 50 p1 amplification mixtures as previously described (Domenech et al., 1997) . The cycling profile consisted of 30 cycles of 1 min at 94 "C, 30 s at 58 "C, and 1 min at 72 O C , followed by a final incubation at 72 "C for 5 min. The ribosomal probe was labelled using the Primea-Gene system (Promega) and 20 pCi [a-32P]dCTP.
RESULTS

Organisms
A total of 71 clinical isolates of M . smegmatis, identified during the 19-year study period from 1978 to the present, and five ATCC reference strains were divided into three groups on the basis of susceptibility to tobramycin and PRA (Wallace et al., 1988) . Thirtyfive (49%) of the clinical isolates and all five ATCC reference strains (including the type strain ATCC 1 9420T) were highly susceptible to tobramycin with MICs < 1 pg ml-l and disk zones > 30 mm, had a single PRA pattern, and were designated M . smegmatis group 1. Twenty-four (38%) of the isolates were intermediately susceptible to tobramycin with MICs of 2-8 pg ml-l and disk zones of 11-30 mm, exhibited a second unique PRA pattern, and were designated as a new species M . srnegmatis group 2. Four additional isolates were highly susceptible to tobramycin, but exhibited the second PRA pattern and were included in the latter group. The remaining eight (1 1 Yo) isolates were resistant to tobramycin with MICs 3 16 pg ml-l and no zones of inhibition by disk diffusion, exhibited a third PRA pattern, and were designated as M . smegmatis group 3.
Eight of eight (100 YO) isolates of M . smegmatis group 3, 22 of 28 (79%) isolates of M . smegmatis group 2, and 34 of 37 (92%) isolates of M . smegmatis group 1 were recovered from non-pulmonary sources including post-traumatic or post-surgical infections of skin, soft tissue and/or bone. Clinical histories were available for seven of eight M . smegmatis group 3 isolates (Table  1 ) and 24 of 28 isolates of M . smegmatis group 2 ( Table   2 ). Six of eight (75 YO) M . smegmatis group 3 infections occurred in Texas, while infections with M . smegmatis group 2 were more ubiquitous and only 11 of 28 (39 Yo) occurred in Texas. Of the M . smegmatis group 3 isolates, three were recovered from surgical wound infections while the remaining four came from traumatic wound infections. Multiple positive cultures were recovered from most patients, and 50% of the wound infections involving M . smegmatis group 3 and 67 Yo of the wound infections involving M . smegmatis group 2 were associated with osteomyelitis (Table 1) . Community-acquired soft tissue infections due to M . smegmatis group 2 were usually osteomyelitis following a motor vehicle accident, often with metal hardware insertion. Pulmonary disease was strongly associated with the histologic finding of lipoid pneumonia, including disease such as achalasia with chronic aspiration (Table 2) .
Morphological and biochemical characterization
Ninety-three per cent of the M . smegmatis group 1 isolates and 78 YO of the M . smegmatis group 2 isolates produced late (10-14 d incubation period) yellow to orange pigmentation in contrast to isolates of M . smegmatis group 3 and M . mageritense that produced no pigment (Table 3) .
The clinical and reference isolates of M . smegmatis group 1, the clinical isolates of M. smegmatis group 2, and the clinical isolates of M . smegmatis group 3 all Table 3 . Growth characteristics, biochemical features, P-lactamase patterns, and susceptibility features of M. srnegrnatis groups 1, 2 and 3
Some data are from a previous study (Wallace et al., 1988 
IJtilization of carbon sources:
Ci t ra te exhibited the classical growth and biochemical profile of M . smeguzatis (Wayne & Kubica, 1986) (Table 3) . Thus, conventional biochemical testing could not distinguish between these three taxa.
Eight of eight (100 Yo) isolates of M . smegnzatis group 2 and three of three (100 YO) isolates of M . smegmatis group 3 tested degraded PAS to catechol, whereas none of the 13 (0%) isolates of the M . smegmatis group 1 were positive for PAS degradation. As noted above, isolates of all three taxa tested exhibited typical M . smegmatis biochemical profiles. This was also true with regard to carbohydrate utilization as sole carbon sources ( 
Susceptibility testing
Isolates of M . smegmatis group 1, M . smegmatis group 2 and M . smegmatis group 3 were susceptible to amikacin and sulfamethoxazole, intermediately susceptible to ciprofloxacin and doxycycline, and variably susceptible to cefmetazole, cefoxitin and clarithromycin. Isolates of M . smegmatis group 3 exhibited higher MICs to amikacin, doxycycline and tobramycin, and lower MICs to cefoxitin than the other two species (Table 4) . Isolates of all three taxa were susceptible to 5 pg ethambutol ml-l and resistant to 25 pg rifampin mi-' and 10 pg isoniazid ml-I (Table 3) Disk zone sizes were determined for 30 pg chloramphenicol and 10 pg tobramycin. Chloramphenicol zones were compared for 40 selected isolates of the three species. Twenty isolates of M . smegmatis group 1, including all five reference strains, had zones of inhibition to the chloramphenicol disk 2 10 mm with a range of 11-44 mm and a mean zone diameter of 17 mm. Twelve M . smegmatis group 2 isolates had zones of inhibition 3 10 mm with a range of 10-27 mm and a mean of 15 mm. Conversely, all eight isolates of M . smegmatis group 3 exhibited zones of 6-12 mm with a mean of 9 mm. Only four of the eight isolates had zones > 10 mm.
Tobramycin disk diffusion zone diameters were determined for 52 isolates and, as noted (Wallace et al., 1988) , were used for initial separation of the three taxonomic groups. Isolates of M . smegmatis group 1 were susceptible to tobramycin by disk diffusion, M . smegmatis group 1 isolates exhibited intermediate susceptibility to tobramycin, and M . smegmatis group 3 isolates were resistant to tobramycin (Table 3) .
H PLC
FL-HPLC chromatograms aligned by using the two internal standards resulted in highly coincident peaks (Fig. 1) . Strains analysed by both FL-HPLC and UV-HPLC yielded highly comparable chromatograms (data not shown). M . smegmatis groups 1,2, 3 and M . mageritense produced two cluster mycolic acid patterns; each cluster contained four to five peaks. These same four taxa differed in the relative abundance of both the front and rear clusters and the peaks within a cluster.
All strains of M . mageritense clustered strongly and apart from the other three taxa (Fig. 2) . M . smegmutis group 3 strains yielded moderately conserved patterns that were intermediate between M . mageritense and some strains of M . smegmatis group 2. M . mageritense and M . smegmatis group 3 were characterized by low front cluster height; the height of the tallest front cluster peak ranged from 0-13 to 0.17 and 0-28 to 0-40 of the tallest rear cluster peak for M . mageritense and M . smegmatis group 3, respectively. M . mageritense and M . smegmatis group 3 strains produced a rear cluster with a single prominent peak at approximately 7.68 min ART; the second tallest rear cluster peak ranged from 0.27 to 037 and 0.46 to 0-69 of the tallest peak for M . mageritense and M . smegmatis group 3, respectively.
Compared to either M . mageritense or M . smegmatis group 3, M . smegmatis group 1 and M . smegmatis group 2 strains showed more diversity in their patterns and exhibited substantial front cluster peaks ; the tallest front cluster peak was > 0.50 of the tallest rear cluster peak, strains M0195, ATCC 14468 and ATCC 35798 excepted. M . smegmatis group 1 was differentiated from M . smegmatis group 3 and M . mageritense by the relative abundance, within the rear cluster, of a peak at approximately 7-48 rnin ART. Most M . smegmatis group 1 and 2 strains were differentiated by the relative height of a peak at approximately 6.14 rnin ART to the tallest front cluster peak; this value was generally 3 0.8 1 and < 0.79 for M . smegmatis groups 1 and 2, respectively.
The HPLC patterns produced by M . smegmatis groups 1,2, 3 and M . mageritense could be distinguished from the closely related patterns produced by the M . fortuitum group ( M . fortuitum, M . .fortuitum third biovariant and M . peregrinum) based on an ART difference of a prominent peak in the front cluster. For M . smegmatis groups 1, 2, 3 and M . mugeritense, this peak ranged from 6-38 to 6.43 min ART. For the M . fortuitum group, the corresponding peak ranged from 6.33 to 6.34 rnin ART.
Examples of the typical HPLC patterns for these three to 3, 4 6 and 9-1 1, respectively. HhaI-derived PRA patterns separated M . mageritense and M . smegmatis group 3 from M . smegmatis groups 1 and 2 (Figs 3 and 4b; lanes 9-1 1,12-14, 1-3 and 4 6 , respectively). PRA patterns with AciI further differentiated all four species (Figs 3 and 5a) . The combination of MspI-, HhaI-, AciI-and BsaHI-derived (Figs 3 and 5b) PRA patterns enabled complete differentiation of all four species.
Isolates of M . smegmatis groups 1 and 2 exhibited only a single PRA pattern with each enzyme. Three of the eight isolates of M . smegmatis group 3 exhibited a second PRA pattern with HaeIII and AciI that differed from the common pattern for the majority of isolates as shown in Fig. 3 . Intraspecies polymorphism with BsaHI resulting in three different PRA patterns that differed from the common pattern for the majority of isolates was also observed for these isolates (Fig. 3) . (Kirschner et al., 1993b) . By comparing the sequence of hypervariable region A, M . smegmatis groups 1 , 2 and 3 were readily differentiated from one another as well as from M . mageritense and members of the M . fortuitum complex (Table 5 ). In addition to other base pair changes, the M . srnegmatis groups 1 and 2 isolates had an extra cytosine inserted at two sites in the hypervariable region A that corresponded to positions 182-1 83 and 199-200 in the comparable region of Escherichia coli.
With the exception of a small group of thermotolerant pigmented species, the former two species are the only rapidly growing mycobacterial species or taxa that have this extra cytosine. Similar insertions were not seen with any of the 6 isolates of M . srnegmatis group 3 (Table 5 ). Isolates were then selected from each of these three groups and these isolates were subjected to complete 16s rRNA sequencing, namely M . smegmatis group 1 (ATCC 19420T), M . smegmatis group 2 (ATCC 700504T), M . mageritense 1336 and M . smegmatis group 3 (ATCC 700009 and ATCC 700010T). The sequence of M . smegmatis group 1 ATCC 19420T was identical to the EMBL sequence for M . smegmatis group 1 ATCC 14468.
A dendrogram illustrating the 16s rRNA phylogenetic relationships among species of the rapidly growing mycobacteria including M . smegmatis groups 1, 2, 3 and M . mageritense is shown in Fig. 6 , while a summary of the degree of relatedness based on Hamming distances is given in Table 6 . M . smegmatis groups I and 2 showed a close phylogenetic relationship with a Hamming distance of 4. These two species share a common branch point in the 16s rRNA phylogenetic tree (Fig. 6 ) and share the characteristic insertion of two cytosine nucleotides in the hypervariable region A as noted above in Table 6 . M . srnegmatis groups 1 and 2 were clustered with other thermotolerant species (e.g. M . phlei, Mycobacterium thermoresistibile, etc.) with this same cytosine insertion.
The two isolates of M. smegmatis group 3 (ATCC 700009 and ATCC 7000 loT) exhibited sequences that differed from those of all previously described species of rapidly growing mycobacteria. They shared a common, but clearly separated, branch point in the 16s rRNA phylogenetic tree that was also shared with M . mageritense as illustrated in Fig. 6 . Five of the six M . smegmatis group 3 isolates including the type strain ATCC 7000 I OT exhibited identical 16s rRNA sequences that differed from that of M . smegmatis group 1 by a Hamming distance of 18, from M . smegmatis group 2 by a distance of 16, from M . mageritense by a distance of 9, and from 28 other species and taxa of rapidly growing mycobacteria by a distance of 16 or greater (Table 6 ). The hypervariable region A rRNA sequence of the sixth M . smegmatis group 3 isolate (ATCC 700009) differed from those of the other five isolates by 4 bp. Unlike the hypervariable region A sequences that were different for each species, the hypervariable region B sequences for M . mageritense, M . smegmatis groups 2 and 3 were 
DNA-DNA hybridization
smegmatis group 3 from all other taxa could also be made by examining the 1001-1027 bp region (i.e.
The mean results of four DNA-DNA hybridization signature sequences designated by the E. coli analyses per sample are shown in Table 8 . Most numbering system) depicted in Table 7. isolates of M . smegmatis group 3 showed 20% or less (Fig. 7) .
DISCUSSION
These three taxonomic groups exhibited typical characteristics of the genus mycobacterium. They grew well aerobically on Middlebrook 7H 10 agar and Lowenstein-Jensen agar, were Gram-posi tive and appeared as acid-fast bacilli after staining with ZiehlNeelsen strain, contained mycobacterial typical mycolic acids and whole-cell fatty acids on HPLC and GLC, respectively, and exhibited more than 95% identity with other mycobacterial 16s rRNA sequences. Their mean of 67 mol% G + C content is within the range of 62-70 mol% typical of the genus mycobacterium (Wayne & Kubica, 1986) . The genetic studies clearly delineated differences between the three M . smegmatis groups, including by PRA of the 65 kDa heat-shock protein gene, 16s rRNA RFLP patterns, 16s rRNA sequences and DNA-DNA pairing experiments. PRA with BstEII resulted in a single band pattern for M . mageritense, and M . smegmatis groups 1, 2 and 3, including the ATCC reference strains, suggesting a close relationship between the groups. As previously demonstrated (Steingrube et al., 1995b; Telenti et al., 1993) (Jost et al., 1995) . In the current study, the relationships between the four species as determined by HPLC mycolic acid patterns were similar to those observed by 16s rRNA sequencing. Previously, Butler & Kilburn (1990) reported that M . smegmatis could not be distinguished from the M . fortuitum group based on their HPLC patterns. However, in the current study a small but consistent difference in peak ART values clearly differentiated M . smegmatis groups 1,2, 3 and M . mageritense from the M . fortuitum group. Consistent with previous reports (Baba et al., 1988; Yassin et al., 1993) , whole-cell fatty acid profiles were very homogeneous among the rapidly growing mycobacteria tested and did not distinguish between Mycobacterium wolinskyi (wo.1ins'ky.i. M.L. gen. n. wolinskyi of Wolinsky, named after Emanuel Wolinsky in honour of, and in recognition for, significant contributions to the study of the non-tuberculous mycobacteria).
A Gram-positive, acid-and alcohol-fast bacillus that produces visible growth in 2-4 d as smooth to mucoid, off-white-to cream-coloured colonies on Middlebrook 7HlO and trypticase soy agar. No pigment is produced and growth occurs at 30, 35 and 45 "C. Isolates grow on MacConkey agar without crystal violet and in the presence of 5 % NaC1, are negative for arylsulfatase activity at 3 d, and are positive for iron uptake and nitrate reductase. They produce low-level semi-quantitative catalase activity that is stable at 68 "C, pH 7.0. The IWGMT has had one major polyphasic study of rapidly growing mycobacteria which was published in 1972 (Kubica et al., 1972) . This included nine strains which clustered with M . smegmatis ATCC 14468. Seven of the isolates were reference strains, and only one strain was of human origin. The current study expands this study to include a large number of human clinical M . smegmatis isolates and defines that they actually consist of three different species. The current study utilized more advanced genetic and chromatographic methods than were available in the 1972 study.
